Role of Platelet Rich Plasma therapy in Skin Repair and wound healing

Efficacy of Autologous Platelet Rich Plasma Therapy in Promoting Cutaneous Wound Healing - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101878

Enrollment

Registered

2026-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Platelet Rich Plasma Therapy: PRP is prepared by collecting venous blood into a tube containing an anticoagulant such as Acid citrate dextrose. The blood undergoes an initial centrifuga

Eligibility

Inclusion criteria

Inclusion criteria: Acute or chronic cutaneous wounds such as anal fissure, anal fistula, diabetic ulcer of more than 4 weeks but less than 12 weeks Age more than 18 years

Exclusion criteria

Exclusion criteria: Anyone who does not consent to the procedure Wounds with active infection

Design outcomes

Primary

Measure	Time frame
Estimate wound healing time with PRP therapy as compared to conventional dressing in terms of Granulation tissue Epithelization Complete coverage To estimate the incidence of infection post-treatment in both comparison groups To estimate cost effectiveness of PRP therapy as compared to conventional dressingTimepoint: Baseline	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Rana Ranjit Singh

Sri Guru Ram Das Institute Of Medical Sciences And Research

gurveer1@gmail.com9876151548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026